About Novartis

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105 000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com

نوفارتس للأدوية

تعمل نوفارتس للأدوية على تطوير مفهوم الطب والعلاج لتحسين حياة الشعوب وإطالتها. وبوصفها شركة عالمية رائدة في مجال صناعة الأدوية، تستخدم نوفارتس أحدث الابتكارات العلمية والتكنولوجيا الرقمية لتصنيع علاجات قادرة على تحويل حياة الشعوب في المناطق الأشد احتياجًا للدواء. وفي إطار سعينا المتواصل لإيجاد علاجات جديدة، نحتل مكانة متقدمة بين أفضل الشركات العالمية في مجال البحث والتطوير. تصل منتجات نوفارتس إلى حوالي 750 مليون شخص على مستوى العالم، ونسعى للتوصل إلى حلول ابتكارية للتوسع في دعم حصول المرضى على أحدث العلاجات. ويعمل حوالي 105 ألف شخص من أكثر من 140 جنسية في شركة نوفارتس على مستوى العالم. للمزيد من المعلومات، يرجى زيارة موقعنا:

www.novartis.com

About Biogen

As pioneers in neuroscience, Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Sir Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today, Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, and is providing the first and only approved treatment to address a defining pathology of Alzheimer’s disease.

The company routinely posts information that may be important to investors on its website at www.biogen-gulf.com. To learn more, please visit www.biogen-gulf.com and follow Biogen on social media – Twitter, LinkedIn, Facebook, YouTube.

Propharma - A pioneer in pharmaceutical distribution services in the UAE. Propharma Medical supplies, established in 2005, is a leading distribution company in the UAE supplying Medical, and Pharmaceutical products from over 20 multinational companies in the healthcare industry. The company has in its portfolio many products from medical supplies to pharmaceuticals and consumer health products. Its focus is not only on pharmaceuticals, but also on quality medical equipment .

It provides a seamless ‘one stop shop’ solution to drug and equipment manufacturers, including distribution, drug registration , inventory control, sales and after-sales service. Operating from new, temperature-controlled and computerized warehouses and backed by advanced delivery vehicles, distribution network is second to none and covers all the towns and cities of the UAE. Cold rooms meeting the most stringent international specifications store medications at temperatures of between 2 and 8 degrees Celsius.

Our group have large chain retail pharmacies & hospitals across the UAE in order to meet customer requirements.

We process registration of companies and products in the Ministry of Health(MOH), Insurance companies and all major formulary committees within the health authorities. www.propharma.ae

Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck generated sales of € 14.8 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. www.merck.com